Related Experiment Videos

Determining Ethnic Disparities Inherent to Tier 3 Vs. Tier 4 Carrier Screening

Vaishali Mehta1, Emily B Rosenfeld2, Julia Geltch3

  • 1Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, Rutgers Robert Wood Johnson, New Brunswick, New Jersey, USA.

Prenatal Diagnosis
|June 22, 2026
PubMed

Insights

Tier 4 carrier screening panels identify more carriers across diverse ethnic groups than traditional Tier 3 panels. Universal Tier 4 screening is recommended for better carrier ascertainment and lower number needed to screen (NNS) in all populations.

Area of Science:

  • Genetics
  • Population Health
  • Medical Diagnostics

Background:

  • Carrier screening panels traditionally use frequency thresholds based on European populations.
  • This approach may lead to ethnic disparities in carrier status ascertainment.
  • Underrepresented ethnic groups may be missed by current screening methods.

Purpose of the Study:

  • Evaluate ethnic disparities in carrier status ascertainment between Tier 3 and Tier 4 screening panels.
  • Assess the utility of Tier 4-only screening in ethnically diverse cohorts.
  • Determine the prevalence and number needed to screen (NNS) for Tier 4 variants across different regions.

Main Methods:

  • Retrospective chart review of 2000 adults undergoing carrier screening.
  • Ethnicity mapping to UN Geoscheme regions for analysis.
  • Calculation of prevalence and NNS for Tier 4-only variants by geographic region and ancestral subgroup.

Main Results:

  • 65.7% of patients carried at least one Tier 4-only variant, with high prevalence across most ancestral subgroups.
  • NNS for Tier 4-only carriers ranged from 1.0 to 2.2, most efficient in Africa, Southeast Asia, and Eastern Europe.
  • Carrier couples were identified with NNS from 7.3 to 58.1 across regions.

Conclusions:

  • Tier 3 panels inadequately identify carriers in underrepresented ethnic groups.
  • Tier 4 panels offer superior carrier ascertainment in diverse populations with lower NNS.
  • Universal Tier 4 carrier screening is supported by these findings.
Abstract